Category: Diabetes Obesity & Metabolism

Diabetes Obesity & Metabolism HCRU

Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort study

Post author By Holden S E, Morgan C L, Qiao Q, Jenkins-Jones S, Berni E R and Currie C J
Post date 20 February 2017

Holden S E, Morgan C L, Qiao Q, Jenkins-Jones S, Berni E R, Currie C J. 20 Feb 2017

Diabetes Diabetes Obesity & Metabolism

Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer

Post author By Holden S E, Jenkins-Jones S, Morgan C L, Schernthaner G and Currie C J
Post date 14 November 2014

Holden S E, Jenkins-Jones S, Morgan C L, Schernthaner G, Currie C J. 14 Nov 2014

Diabetes Obesity & Metabolism

Mortality Risk with Sulphonylureas Compared to Metformin

Post author By Holden S E and Currie C J
Post date 1 October 2014

Holden S E, Currie C J. 18 Feb 2014

Diabetes Obesity & Metabolism

Optimizing clinical outcomes resulting from glucose-lowering therapies in type 2 diabetes: increased confidence about the DPP-4 inhibitors and continued concerns regarding sulphonylureas and exogenous insulin

Post author By Currie C J and Holden S E
Post date 7 July 2014

Currie C J, Holden S E. 07 Jul 2014

Diabetes Obesity & Metabolism

Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls

Post author By Bannister Ch A, Holden S E, Jenkins-Jones S, Morgan C L, Halcox J P, Schernthaner G, Mukherjee J and Currie C J
Post date 7 July 2014

Bannister Ch A, Holden S E, Jenkins-Jones S, Morgan C L, Halcox J P, Schernthaner G, Mukherjee J, Currie C J. 07 Jul 2014

Diabetes Obesity & Metabolism

Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality

Post author By Morgan C L, Mukherjee J, Jenkins-Jones S, Holden S E and Currie C J
Post date 22 May 2014

Morgan C L, Mukherjee J, Jenkins-Jones S, Holden S E, Currie C J. 22 May 2014

Diabetes Obesity & Metabolism

Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study

Post author By Morgan C L, Mukherjee J, Jenkins-Jones S, Holden S E and Currie C J
Post date 11 April 2014

Morgan C L, Mukherjee J, Jenkins-Jones S, Holden S E, Currie C J. 11 Apr 2014

Diabetes Obesity & Metabolism

How many people inject insulin? UK estimates from 1991 to 2010

Post author By Holden S E, Gale E A M, Jenkins-Jones S and Currie C J
Post date 10 January 2014

S. E. Holden, E. A. M. Gale, S. Jenkins-Jones, C. J. Currie. 10 Jan 2014

Diabetes Obesity & Metabolism

The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010

Post author By Holden S E, Barnett A H, Peters J R, Jenkins-Jones S, Poole C D, Morgan C L and Currie C J
Post date 15 May 2013

Holden S E, Barnett A H, Peters J R, Jenkins-Jones S, Poole C D, Morgan C L, Currie C J. 15 May 2013

Diabetes Obesity & Metabolism

Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs

Post author By Morgan C L, Jenkins-Jones S, Evans M, Barnett A H, Poole C D and Currie C J
Post date 22 December 2011

Morgan C L, Jenkins-Jones S, Evans M, Barnett A H, Poole C D, Currie C J. 22 Dec 2011

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Copyright^© Human Data Sciences – All rights reserved

Site by Create Summit

Copyright © Human Data Sciences – All rights reserved